Sort
15,842 grants matching “pancreatic cancer”
Project 1: Employing CD11b-Agonists to Render PDAC Responsive to Immunotherapy
$357,273David G Denardo · Washington University · P50 · FY2023 · CA
Targeting macrophages for immunotherapy in pancreatic cancer
$357,238Gregory L Beatty · University Of Pennsylvania · R01 · FY2019 · CA
Molecular dissection of pancreatic ductal adenocarcinoma
$357,227Brian C Lewis · Univ Of Massachusetts Med Sch Worcester · R01 · FY2007 · CA
Tailoring Therapy to Pancreatic Cancer Subtypes
$357,141Eric Collisson · University Of California, San Francisco · R01 · FY2019 · CA
TBEL Admin Core
$356,903Anirban Maitra · University Of Tx Md Anderson Can Ctr · U54 · FY2024 · CA
Biological Activity of Ras Oncogenes
$356,891Channing J Der · Univ Of North Carolina Chapel Hill · R01 · FY2012 · CA
Biological Activity of Ras Oncogenes
$356,891Channing J Der · Univ Of North Carolina Chapel Hill · R01 · FY2011 · CA
Stress-adaptation in obesity-associated pancreatic cancer
$356,850Elda Grabocka · Thomas Jefferson University · R37 · FY2020 · CA
Stress-adaptation in obesity-associated pancreatic cancer
$356,850Elda Grabocka · Thomas Jefferson University · R37 · FY2022 · CA
Role of Lipocalin 2 in Pancreatic Cancer
$356,850Zobeida Cruz-Monserrate · Ohio State University · R01 · FY2018 · CA
Synthetic Lethal Targeting of Growth Factor Receptors
$356,850Blake Peterson · Ohio State University · R01 · FY2020 · CA
Role of Lipocalin 2 in Pancreatic Cancer
$356,850Zobeida Cruz-Monserrate · Ohio State University · R01 · FY2022 · CA
Stress-adaptation in obesity-associated pancreatic cancer
$356,850Elda Grabocka · Thomas Jefferson University · R37 · FY2021 · CA
Role of Lipocalin 2 in Pancreatic Cancer
$356,850Zobeida Cruz-Monserrate · Ohio State University · R01 · FY2021 · CA
Synthetic Lethal Targeting of Growth Factor Receptors
$356,850Blake Peterson · Ohio State University · R01 · FY2021 · CA
Role of Lipocalin 2 in Pancreatic Cancer
$356,850Zobeida Cruz-Monserrate · Ohio State University · R01 · FY2020 · CA
Stress-adaptation in obesity-associated pancreatic cancer
$356,850Elda Grabocka · Thomas Jefferson University · R37 · FY2018 · CA
The JAZF1 Gene and Type 2 Diabetes
$356,828Jeffrey Sklar · Yale University · R01 · FY2009 · DK
Molecular aspects of gastrinoma
$356,814Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
Origins and functions of pancreatic cancer-associated fibroblasts
$356,807Mara H. Sherman · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Mechanisms of cancer cell chemotaxis in perineural invasion
$356,747Richard J Wong · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
Genomic Clinical Variant Expert Curation Panel for Monogenic Diabetes: A Gateway to Precision Medicine in Diabetes Mellitus
$356,709Toni I. Pollin · University Of Maryland Baltimore · U24 · FY2023 · HD
Spread of Replicating Adenovirus in Pancreatic Tumors
$356,539John G. Hay · New York University School Of Medicine · R01 · FY2007 · CA
Priming pancreatic ductal adenocarcinoma using blood thinners to sensitize the efficacy of checkpoint immunotherapy
$356,500Taslim A Al-Hilal · University Of Texas El Paso · SC1 · FY2022 · GM
Sepsis diagnosis using chemically modified DNA aptamers
$356,500Bharat Gawande · Aptus Biosciences Llc · R43 · FY2025 · GM